据安东尼·帕拉佐报道，在面临提高报价的压力后，CVC资本 Partners将收购意大利制药公司Recordati的全部股份的报价提高至105亿欧元（约合118亿美元）。
Capital Partners raised its offer to buy all of Italian pharmaceutical firm Recordati to €10.5 billion ($11.8 billion) after coming under pressure to raise the bid.
周二发布的一份声明显示，新的收购报价为每股53欧元，而此前的报价为每股51.29欧元。
The new offer of €53 per share, announced in a statement on Tuesday, compares with the earlier price of €51.29.
CVC目前已是Recordati的少数股东，今年早些时候曾提出收购该公司剩余股份。股东Palliser Capital则要求董事会撤回支持，除非报价提高至每股60欧元。
CVC, which is already a minority owner of Recordati, offered to buy the rest of the pharmaceutical firm earlier this year. Shareholder Palliser Capital has called on the board to withdraw its support unless the offer is raised to €60.
周一，Recordati的股价在米兰股市收盘时为52.20欧元。
Recordati shares closed at €52.20 on Monday in Milan.